← Eichor
Study identifier: NCT07596498 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of the Effectiveness and Learning Curve of Laparoscopic Pectopexy Versus Laparoscopic Sacrocolpopexy

Condition: Apical Prolapse  ·  Sponsor: Ain Shams University

PhaseNA
Planned participants30
Who can joinFemale, 40 Years to 75 Years
Healthy volunteersNo

About this study

Pelvic organ prolapse, particularly apical prolapse, is a common condition among aging women, and laparoscopic sacrocolpopexy is considered the standard surgical treatment due to its high anatomical success. However, it poses technical challenges and risks related to sacral dissection. Laparoscopic pectopexy, a newer technique using the iliopectineal ligament for mesh fixation, offers a safer anatomical route with shorter operative time and fewer complications. The previous studies evaluate the sacrocolpopexy and pectopexy are all retrospective. This study is prospective randomized controlled study that adds Comparison on the success rate and learning curve of pectopexy versus sacrocolpopexy .

This description comes directly from the study's public registry record.

Talk to the study team

Rafael Elkess Gabriel William, Resident  ·  +201223657844  ·  rafailogebrael@gmail.com

Ahmed Farouk, professor  ·  +201005003309  ·  drfarouk77@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ain Shams University HospitalCairo, Abbasia, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07596498